Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.01
-0.64 (-2.71%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.39 billion as of September 25, 2026. Its market cap has increased by 259.04% in one year.
Market Cap
2.39B
Enterprise Value
2.00B
1-Year Change
259.04%
Ranking
Category
Stock Price
$23.01
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.39B, an increase of 239.16%. That is a compound annual growth rate of 21.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.39B | 24.18% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.51B |
| Immunome | 2.45B |
| Beam Therapeutics | 2.45B |
| Celldex Therapeutics | 2.45B |
| Harmony Biosciences Holdings | 2.40B |
| SELLAS Life Sciences Group | 2.37B |
| Vera Therapeutics | 2.37B |
| Viridian Therapeutics | 2.30B |